Electronic Quality Management System built on a low-code aPaaS platform, providing 11 integrated modules for pharmaceutical and life sciences quality management with AI-powered automation.
AmpleLogic eQMS is a comprehensive web-based Electronic Quality Management System built on the company's proprietary aPaaS (Application Platform as a Service) platform. The solution provides 11 integrated modules covering the complete quality management lifecycle: CAPA, Change Control, Deviations, Market Complaints, Document and Training Management, OOS/OOT, Audit Management, Vendor Qualification, Incident Reporting, Product Recall, and Quality Risk Management.
The platform is built on a low-code/no-code foundation, enabling rapid customisation without extensive coding. AmpleLogic emphasizes "10X Faster Deployment", "ROI in 3 Months", and "98% Project Success Rate" (vs 56% industry average). The system is designed specifically for heavily regulated life sciences industries including pharmaceuticals, biotechnology, medical devices, CDMOs, and API manufacturers.
AmpleLogic eQMS provides AI-driven capabilities for OOS/OOT detection, CAPA management, and Change Control automation. The platform ensures compliance with global regulatory standards including FDA 21 CFR Part 11, EU Annex 11, cGMP, GAMP 5, and multiple ISO certifications (9001, 14001, 18001/45001, 31000). Integration with existing ERP systems like SAP is supported, with analytics providing real-time data insights for proactive quality management.
AmpleLogic markets the platform to mid-market pharmaceutical and biotech companies, CDMOs, and medical device manufacturers, positioning it around rapid implementation, customisation flexibility, and regulatory compliance. AmpleLogic has deployed 12+ products serving 100+ life science companies globally, with presence in India, the Middle East, and other pharmaceutical markets. Notable customers include Serum Institute, Cipla, Sun Pharma, Biocon, Teva, and Bharat Biotech.
Pharmaceutical Edition
AmpleLogic aPaaS platform and all solutions are specifically designed exclusively for life sciences, pharmaceuticals, biotech, medical devices, and related regulated industries. Platform launched June 2024.
Core Capabilities
FDA & GxP Compliance
International Standards
Data Integrity & Validation
AmpleLogic eQMS is built on the company's proprietary aPaaS (Application Platform as a Service) platform with low-code/no-code capabilities, launched in June 2024. Primary deployment is cloud-based SaaS model hosted on AmpleLogic's infrastructure. Whether on-premise deployment is offered is undisclosed.
The platform is web-based and accessible via browser (English language only as of 2025). No native mobile app is disclosed; a responsive web interface supports mobile browser access. The low-code/no-code architecture enables rapid customisation and configuration without extensive coding.
Integration capabilities include connectivity with ERP systems, specifically highlighting SAP integration. The platform provides REST APIs for custom integrations and data exchange. As businesses grow, AmpleLogic scales to accommodate increased data volumes and user numbers. The system supports multi-tenant architecture with data isolation for security.
AmpleLogic emphasizes performance metrics: "10X Faster Deployment", "98% Project Success Rate" (vs 56% industry average), and ability to implement solutions in one month on existing infrastructure without customization costs.
Per-user pricing starts in the range of $10–$100 according to third-party analysis; specific pricing is not published on the vendor's website. AmpleLogic eQMS uses a subscription-based pricing model. Enterprise pricing and custom quotes are available by contacting sales.
The platform is positioned as cost-effective with emphasis on maximizing benefits at minimal cost. Marketing materials highlight "fits perfectly with packaged solutions" and "runs on existing infrastructure" without incurring customization costs. ROI is claimed within 3 months, with 6-month ROI guarantee mentioned in some sources.
Free demo is available on request through the vendor website. Free trial availability is undisclosed. The platform scales pricing based on user numbers and data volumes, accommodating business growth. Annual or multi-year subscription terms are standard for enterprise customers.
Implementation costs benefit from rapid deployment (1–3 months) and minimal customisation requirements. No explicit pricing for validation services or professional services is published; these are likely included in enterprise contracts or quoted separately.
Typical implementation timeline is 1–3 months, with some customers reporting go-live in one month; AmpleLogic markets this as "10X Faster Deployment". The platform's low-code/no-code architecture minimises customisation complexity and accelerates configuration.
Implementation services include platform configuration, data migration support, user training, and validation assistance for pharmaceutical clients. The company claims "98% Project Success Rate" compared to 56% industry average. ROI is typically achieved within 3 months of implementation.
The platform runs on existing infrastructure without requiring specialized hardware or significant IT investment. Migration from paper-based processes or legacy systems is supported through the platform's flexible data import capabilities. Professional services and implementation support are provided by AmpleLogic's team, with partnership network including QA Connect Management Consulting for medical device implementations (announced February 2024).
Validation support includes CSV (Computer System Validation) guidance, validation documentation, and compliance with GAMP 5 standards for pharmaceutical implementations. The platform's immutable audit trails and electronic signature capabilities support FDA inspection readiness.
Anonymous feedback from pharmaceutical professionals using this solution
4.9 out of 5
Based on 85 verified reviews
What Users Like
Users describe the interface as intuitive and easy to use, requiring minimal training and enabling quick team adoption. Reviews cite tracking of audits, version control, and CAPAs, supporting compliance readiness. AmpleLogic's technical support is described as responsive, supporting smooth implementation and ongoing use. The platform integrates with existing systems including SAP, streamlining data flow and reducing manual data entry. The low-code/no-code platform enables rapid customisation without extensive coding. Customer satisfaction score is 81%, with 98% of users willing to recommend the product; reviews describe satisfaction sustained over multi-year usage periods.
What Users Dislike
AmpleLogic eQMS currently supports only English, which may be a barrier for non-English-speaking users and international implementations. Some users report that certain advanced configurations may require vendor assistance. Review volume across platforms is limited, constraining feedback on drawbacks across diverse use cases.
Help the community
Share your experience with AmpleLogic eQMS anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section